Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 131

    1.

    Phenobarbital effects in cholestatic liver diseases.

    Bloomer JR, Boyer JL.

    Ann Intern Med. 1975 Mar;82(3):310-7.PMID: 1115464 [PubMed - indexed for MEDLINE]Related articles

    2.

    Effects of phenobarbital on bile salt metabolism in cholestasis due to intrahepatic bile duct hypoplasia.

    Stiehl A, Thaler MM, Admirand WH.

    Pediatrics. 1973 Jun;51(6):992-7. No abstract available. PMID: 4710459 [PubMed - indexed for MEDLINE]Related articles

    3.

    Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease.

    Azer SA, Coverdale SA, Byth K, Farrell GC, Stacey NH.

    J Gastroenterol Hepatol. 1996 Mar;11(3):208-15.PMID: 8742915 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effect of cholestyramine and phenobarbital on pruritus and serum bile acid levels in cholestasis of pregnancy.

    Laatikainen T.

    Am J Obstet Gynecol. 1978 Nov 1;132(5):501-6.PMID: 717452 [PubMed - indexed for MEDLINE]Related articles

    5.

    Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine.

    Heikkinen J, Mäentausta O, Ylöstalo P, Jänne O.

    Eur J Obstet Gynecol Reprod Biol. 1982 Dec;14(3):153-62.PMID: 7160524 [PubMed - indexed for MEDLINE]Related articles

    6.

    Efficacy and safety of long-term phenobarbital therapy of familial cholestasis.

    Ghent CN, Bloomer JR, Hsia YE.

    J Pediatr. 1978 Jul;93(1):127-32.PMID: 650323 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of phenobarbital in a case of extrahepatic cholestasis.

    Metreau JM, Bismuth H, Franco D, Dhumeaux D.

    Gastroenterology. 1975 Mar;68(3):567-71.PMID: 1112459 [PubMed - indexed for MEDLINE]Related articles

    8.

    The effects of phenobarbital on bile salts and bilirubin in patients with intrahepatic and extrahepatic cholestasis.

    Stiehl A, Thaler MM, Admirand WH.

    N Engl J Med. 1972 Apr 20;286(16):858-61. No abstract available. PMID: 5061069 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Treatment of cholestatic liver diseases]

    Gatzen M, Pausch J.

    Med Klin (Munich). 2002 Mar 15;97(3):152-9. Review. German. PMID: 11957790 [PubMed - indexed for MEDLINE]Related articles

    10.

    Serum bile acids in primary biliary cirrhosis.

    Bloomer JR, Allen RM, Klatskin G.

    Arch Intern Med. 1976 Jan;136(1):57-61.PMID: 1247336 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of phenobarbital on biliary lipid metabolism in children with chronic intrahepatic cholestasis.

    Becker M, von Bergmann K, Rotthauwe HW, Leiss O.

    Eur J Pediatr. 1984 Nov;143(1):41-4.PMID: 6510429 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Treatment of cholestatic liver disease]

    Pleşa A.

    Rev Med Chir Soc Med Nat Iasi. 2003 Oct-Dec;107(4):733-6. Review. Romanian. PMID: 14756010 [PubMed - indexed for MEDLINE]Related articles

    13.

    The effect of phenobarbital on patients with Dubin-Johnson syndrome.

    Merdler C, Burke M, Shani M, Felner S, Lurie I.

    Digestion. 1976;14(5-6):394-9.PMID: 976623 [PubMed - indexed for MEDLINE]Related articles

    14.

    Ursodeoxycholic acid therapy in children with cholestatic liver disease.

    Dinler G, Koçak N, Yüce A, Gürakan F, Ozen H.

    Turk J Pediatr. 1999 Jan-Mar;41(1):91-8.PMID: 10770681 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis.

    Rudolph G, Endele R, Senn M, Stiehl A.

    Hepatology. 1993 Jun;17(6):1028-32.PMID: 8514251 [PubMed - indexed for MEDLINE]Related articles

    16.

    Plasma antioxidant levels in chronic cholestatic liver diseases.

    Floreani A, Baragiotta A, Martines D, Naccarato R, D'odorico A.

    Aliment Pharmacol Ther. 2000 Mar;14(3):353-8.PMID: 10735930 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effect of phenobarbital on hepatic transport and excretion of 131 I-rose bengal in children with cholestasis.

    Thaler MM.

    Pediatr Res. 1972 Feb;6(2):100-10. No abstract available. PMID: 4403062 [PubMed - indexed for MEDLINE]Related articles

    18.

    Increased intercellular adhesion molecule-1 serum concentration in cholestasis.

    Polzien F, Ramadori G.

    J Hepatol. 1996 Dec;25(6):877-86.PMID: 9007716 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of phenobarbital on hyperbilirubinemia, bile acid metabolism, and microsomal enzyme activity in chronic intrahepatic cholestasis of childhood.

    Sharp HL, Mirkin BL.

    J Pediatr. 1972 Jul;81(1):116-26. No abstract available. PMID: 5034859 [PubMed - indexed for MEDLINE]Related articles

    20.

    Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis.

    Lim AG, Jazrawi RP, Ahmed HA, Levy JH, Zuin M, Douds AC, Maxwell JD, Northfield TC.

    Hepatology. 1994 Oct;20(4 Pt 1):882-8.PMID: 7927229 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data